Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

SGX-listed Acromec, which designs and builds medical and sterile cleanrooms, has secured another contract in the healthcare sector valued at S$2.9 million (US$2.1 million). It is expected to be completed by the end of the year.
Sydney-based 1st Group, the Australian digital health, media and technology group, has appointed Richard Rogers as chief financial officer. He joins from Lenovo Australia & New Zealand.
Asia-focused market expansion services provider DKSH is to sell its healthcare business in China to Warburg Pincus for SFr100 million (US$100.7 million).
Summerset Group, New Zealand’s third-largest listed retirement village operator, has said that it expects underlying half year profits to jump between 21% and 26% to NZ$43 million (US$29.4 million) and NZ$45 million.
Patient flow management firm Jayex Healthcare has signed a binding licence agreement with medical cannabis company MediCann NZ under which it will be granted the exclusive use and application of its technologies in New Zealand in connection with their proposed sale and distribution of medical cannabis products in line with the expected deregulation in New Zealand of medical cannabis.
IDS Medical Systems Group, a leading medical supply-chain solutions company in Asia, and Tencent-backed We Doctor have formed idsMED WeDoctor China, the country’s first smart medical supply chain solutions and procurement company.
Australian medtech company Resonance Health has signed an alliance partner agreement with Blackford Analysis which grants it rights to integrate and combine Resonance Health products with, or sell and license Resonance Health products in connection with the host application.
Malaysian medical services company Adventa has scrapped plans to raise M$80.2 million (US$20.3 million) after Top Glove Corporation, the world’s largest rubber glove manufacturer, announced legal proceedings against its parent Adventa Capital and two of its directors.
Singapore government investment company Temasek Holdings has taken a US$50 million stake in Asia Healthcare Holdings (AHH), an operating and investment platform founded by TPG Capital.
Sisram Medical, a Israeli subsidiary of Shanghai Fosun Pharmaceutical, and which manufactures medical aesthetics devices, has laid out its vision to become a global medtech leader, leveraging its solid funding channels, strong r&d capabilities and comprehensive portfolio of products.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




Stock markets in Asia continued to add to yesterday’s gains and mostly rallied today. They were led by the Nikkei. It bounced 1.5%, powered by the yen which hit a six-month low against the US dollar. Korea’s Kospi rose 0.9% and the Hang Seng added a respectable 0.48%. All good news, but the rally today was mostly relief. Investors are still waiting for China’s response to US threats to impose a 10% tariff on US$200 billion of products as soon as September. There are fears too that the US might double down, especially after China reported a significant US$29 billion trade surplus with the US in June. The Shanghai Composite was last seen off by 0.12%. But it is not all bad news. Last night US treasury secretary Steven Mnuchin hinted that he was prepared to return to the trade negotiation table. The US is “available”, he said, if China “wants to make serious efforts to make structural changes”.



HealthInvestor Asia twitter feed


HealthInvestor UK